Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Sandoz Ltd, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
Omeprazole 40 mg Powder for Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for infusion. The powder for solution for infusion is a white to almost white powder. The reconstituted solution has a pH of about 9-10.5. The osmolarity of the solution reconstituted with 100 ml of 5% glucose solution is about 0.297Osmol/kg. The osmolarity of the solution reconstituted with 100 ml of 0.9% saline is about 0.282 Osmol/kg. |
Each vial of powder for solution for infusion contains omeprazole sodium, equivalent to 40 mg omeprazole.
After reconstitution (see section 6.6), each 1 ml contains 0.4 mg omeprazole.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Omeprazole |
Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing. |
| List of Excipients |
|---|
|
Sodium hydroxide (for pH adjustment) |
10 ml colourless glass vial Type I with a red bromobutyl rubber stopper, and an aluminium cramping cap with polypropylene cap.
Pack sizes: 1, 5, 10 or 20 vials.
Not all pack sizes may be marketed.
Sandoz Ltd, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
PL 04416/0701
Date of first authorisation: 22 April 2008
Date of latest renewal: 19 December 2011
| Drug | Countries | |
|---|---|---|
| OMEPRAZOLE | Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
